Location: San Mateo, CA or NYC
About the Team
Genesis Molecular AI is at the frontier of applying large-scale AI to drug discovery. We are building AI systems that operate at the intersection of machine learning, chemistry, and biology, with the goal of enabling real breakthroughs in medicine.
Our teams are mission-driven, deeply technical, and motivated by the opportunity to work on problems that matter. This is not incremental work. We are defining what the "machine" looks like: the models, the data, the infrastructure, and the workflows that allow science and AI to meet in meaningful ways. Impact comes from ownership, curiosity, and a willingness to engage directly with hard, unsolved problems.
The Platform Engineering team builds and operates the infrastructure that underpins everything we do, from large-scale data ingestion and storage, to distributed model training, evaluation, and production inference.
About the Role
We are looking for a Head of Platform Engineering to lead our infrastructure and enable the next generation of AI-driven drug discovery. In this role you will lead this function end to end.
This is a senior leadership role for someone who enjoys working close to the systems themselves. You will be responsible not only for the technical architecture, but for how the platform earns trust, adoption, and impact across the organization.
While this is a leadership role, it is also a hands-on role. At Genesis, credibility comes from understanding the work deeply. You should expect to engage directly with the codebase, technical designs, and architectural decisions.
This role sits at the intersection of cutting-edge AI, large-scale systems, and real-world scientific impact. If you're excited by building reliable platforms for training and deploying SOTA AI models, and want to work on AI that is genuinely good for humanity, this is a unique opportunity.
If this sounds interesting, please reach out, we'd love to talk!
About Genesis Molecular AI
Genesis Molecular AI is pioneering foundation models for molecular AI to unlock a new era of drug design and development. The company's generative and predictive AI platform, GEMS (Genesis Exploration of Molecular Space), integrates AI and physics into industry-leading models to generate and optimize drug molecules, including the breakthrough generative diffusion model Pearl for structure prediction. Genesis has raised over $300 million from leading AI, tech and life science-focused investors, signed multiple AI-focused research collaborations with major pharma partners, and is deploying GEMS to advance an internal therapeutics pipeline for a variety of high-impact targets.
Genesis is headquartered in San Mateo, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.